Treatment Approach for Abnormal DHEA Levels
Diagnostic Approach for Abnormal DHEA Levels
- Evaluate low DHEA levels in context of overall adrenal function with paired measurement of serum cortisol and plasma ACTH to determine if primary adrenal insufficiency is present 2
- Consider morning levels of ACTH, cortisol, basic metabolic panel, renin, and aldosterone for comprehensive evaluation of low DHEA levels 2
- For indeterminate results, standard dose ACTH stimulation testing may be necessary for low DHEA levels 2
- Elevated DHEA-S levels may indicate adrenocortical carcinoma (ACC), especially when accompanied by clinical signs of virilization 3
- Serum testing for excess androgen should be performed in cases of suspected ACC and/or when clinical signs of virilization are present 3
Treatment Recommendations
- Primary treatment for primary adrenal insufficiency should focus on glucocorticoid and mineralocorticoid replacement 2
- DHEA supplementation can be considered as adjunctive therapy after primary hormone replacement is established for primary adrenal insufficiency 2
- A 6-month trial of DHEA replacement (typically 25 mg daily) can be offered to female patients with persistent lack of libido and/or low energy levels despite optimized glucocorticoid and mineralocorticoid replacement 1
- DHEA supplementation can be offered at doses of 10-50 mg daily, with 25 mg being a common starting dose for isolated low DHEA 1, 2
- Unilateral adrenalectomy is recommended for adrenal masses causing androgen excess, with minimally-invasive surgery when feasible 3
Special Considerations
- DHEA supplementation has shown significant improvements in sexual desire, arousal, pain, and overall sexual function in clinical trials for women 1
- DHEA supplementation should not be prescribed to men who are currently trying to conceive, as it can suppress normal sperm production 1
Monitoring Protocol
- Baseline hormone levels should be established before initiating DHEA therapy 1
- Follow-up hormone levels should be maintained in the normal range when measured in the morning prior to DHEA ingestion 1
- Clinical effectiveness should be assessed after 6 months to determine whether to continue DHEA therapy 1
Safety Considerations
- Long-term effects of DHEA replacement therapy are not fully known, so treatment should be used with caution 1, 2
- DHEA should be used with particular caution in cancer survivors receiving aromatase inhibitor therapy 1